Hypoglycemia in glyburide-treated gestational diabetes: Is it dose-dependent?

Obstetrics and Gynecology

Volumn 117, Issue 2, 2011, Pages 349-353

  Brustman, Lois ^a   Langer, Oded ^a   Scarpelli, Sophia ^a   El Daouk, Manal ^a   Fuchs, Anna ^a   Rosenn, Barak ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; INSULIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EVENING DOSAGE; FEMALE; FUNCTIONAL STATUS; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MORNING DOSAGE; NEUROLOGIC DISEASE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RESUSCITATION;

ADULT; DIABETES, GESTATIONAL; FEMALE; GLYBURIDE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 79251564911     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0b013e318207782a     Document Type: Article

References (16)

1. Gabbe SG, Graves CR. Management of diabetes mellitus complicating pregnancy. Obstet Gynecol 2003;102:857-68.
2. Saade G. Gestational diabetes mellitus: a pill or a shot? Obstet Gynecol 2005;105:456-7.
3. Greene MF. Oral Hypoglycemic drugs for gestational diabetes. N Engl J Med 2000;343:1178-9.
4. Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007;30(suppl 2):S251-60.
5. Kremer CJ, Duff P. Glyburide for the treatment of gestational diabetes. Am J Obstet Gynecol 2004;190:1438-9.
6. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes. N Engl J Med 2000;343:1134-8.
7. Brunton LB, Lazo JS, Parker KL, editors. Goodman & Gilman's The pharmacological basis of therapeutics. 11th ed. New York (NY): McGraw-Hill; 2005.
8. Carpenter MW, Coustan DR. Criteria for screening tests of gestational diabetes. Am J Obstet Gynecol 1982;144:763-8.
9. Langer O, Brustman L, Anyaegbunam A, Mazze R. The significance of one abnormal glucose tolerance test value on adverse outcome in pregnancy. Am J Obstet Gynecol 1987;157:758-63.
10. Langer O, Anyaegbunam A, Brustman L, Divon M. Management of women with one abnormal oral glucose tolerance test value reduces adverse outcome in pregnancy. Am J Obstet Gynecol 1989;161:593-9.
11. Langer O, Yogev Y, Xenakis EM, Rosenn B. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome. Am J Obstet Gynecol 2005;192:134-9.
12. Langer O, Berkus M, Brustman L, Anyaegbunam A, Mazze R. Rationale for insulin management in gestational diabetes mellitus. Diabetes 1991;40(suppl 2):186-90.
13. American Diabetes Association Workgroup on Hypoglycemia. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005;28(5):1245-9.
14. Yogev Y, Ben-Haroush A, Chen R, Rosenn B, Hod M, Langer O. Undiagnosed asymptomatic hypoglycemia: diet, insulin, and glyburide for gestational diabetic pregnancy. Obstet Gynecol 2004;104:88-93.
15. Freinkel N, Metzger BE, Nitzan M, Hare JW, Shambaugh GE 3rd, Marshall RT, et al. “Accelerated starvation” and mechanisms for the conservation of maternal nitrogen during pregnancy. Israel J Med Sci 1972;8:426-39.
16. Hebert MF, Ma X, Naraharisetti SB, Krudys KM, Umans JG, Hankins GD, et al. Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice.Clin Pharmacol Ther 2009;85:607-14.